CYP2C19 STATUS AND OUTCOMES IN THE EUCLID TRIAL
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(18)32628-7
Abstract: Cytochrome P450 2C19 (CYP2C19) is a hepatic enzyme involved in metabolism of clopidogrel to its active metabolite. Polymorphisms with 2 loss-of-function (LOF) alleles lead to poor metabolism of clopidogrel, but little is known about the… read more here.
Keywords: outcomes euclid; cardiology; cyp2c19 status; status outcomes ... See more keywords